RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $12,000 | +9.1% | 5,832 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | -26.7% | 5,832 | 0.0% | 0.00% | – |
| Q2 2019 | $15,000 | 0.0% | 5,832 | 0.0% | 0.00% | – |
| Q1 2019 | $15,000 | +400.0% | 5,832 | +315.1% | 0.00% | – |
| Q4 2018 | $3,000 | -40.0% | 1,405 | 0.0% | 0.00% | – |
| Q3 2018 | $5,000 | 0.0% | 1,405 | 0.0% | 0.00% | – |
| Q2 2018 | $5,000 | 0.0% | 1,405 | 0.0% | 0.00% | – |
| Q1 2018 | $5,000 | – | 1,405 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |